Author's response to reviews Title:Adaptation of Magnetic Resonance Imaging and Stereotactic Irradiation for Management of Brain Metastasis-attenuated Benefits of Prophylactic Cranial Irradiation in Patients with Limited-stage Small Cell Lung Cancer Authors:
نویسندگان
چکیده
Yuichi Ozawa ([email protected]) Minako Omae ([email protected]) Masato Fujii ([email protected]) Takashi Matsui ([email protected]) Masato Kato ([email protected]) Shinya Sagisaka ([email protected]) Kazuhiro Asada ([email protected]) Masato Karayama ([email protected]) Toshihiro Shirai ([email protected]) Kazumasa Yasuda ([email protected]) Yutaro Nakamura ([email protected]) Naoki Inui ([email protected]) Kazunari Yamada ([email protected]) Koushi Yokomura ([email protected]) Takafumi Suda ([email protected])
منابع مشابه
Treatment of Brain Metastasis from Lung Cancer
Brain metastases are not only the most common intracranial neoplasm in adults but also very prevalent in patients with lung cancer. Patients have been grouped into different classes based on the presence of prognostic factors such as control of the primary tumor, functional performance status, age, and number of brain metastases. Patients with good prognosis may benefit from more aggressive tre...
متن کاملProphylactic Cranial Irradiation for Extensive Small-Cell Lung Cancer.
Small-cell lung cancer (SCLC) has a high predilection for metastasizing to the brain after chemotherapy. This has been blamed on the blood-brain barrier, which prevents chemotherapy from penetrating into the brain, thus creating a sanctuary site. It has been estimated that up to three quarters of patients with SCLC will eventually develop brain metastases. This led investigators to administer p...
متن کاملCurrent concepts in the management of small cell lung cancer
Small cell lung cancer (SCLC) has a clinical course that is distinct from its more common counterpart non-small cell lung cancer. SCLC continues to be a major clinical problem, with an aggressive clinical course and short disease-free duration after initial therapy. Current optimal treatment consists of chemotherapy with platinum-etoposide, given concurrently with thoracic irradiation in patien...
متن کاملSmall-Cell Lung Cancer: Therapeutic Changes
Almost 40% of patients with newly diagnosed small-cell lung cancer (SCLC) have disease confined to the ipsilateral hemithorax and within a single radiation port, ie, limited-stage disease. The median survival for this group of patients after treatment is approximately 15 months, with one in every four patients surviving 2 years. Current optimal treatment consists of chemotherapy with platinum/e...
متن کاملSBRT Treatment of Metachronous Small-Cell and Non-Small-Cell Lung Carcinomas in a Patient with Severe COPD
Stereotactic body radiotherapy (SBRT) has not been widely employed in the treatment of limited-stage (LS) small-cell lung cancer (SCLC), although SBRT finds particular utility in patients medically unfit to undergo surgical resection or radiotherapy with conventional fields. The authors present the case of a 61-year-old female smoker with severe chronic obstructive pulmonary disease (COPD), dia...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
دوره شماره
صفحات -
تاریخ انتشار 2015